Skip to main content

Ambroxol (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Ambroxol (ambroxol systemic) is used to treat Expectoration.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R05CB06

CAS registry number (Chemical Abstracts Service)

0018683-91-5

Chemical Formula

C13-H18-Br2-N2-O

Molecular Weight

378

Therapeutic Categories

Mucolytic agent

Expectorant

Chemical Name

trans-4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol (WHO)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.